These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 26578322)
1. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis. Hu G; Zhu W; Yang W; Wang H; Shen L; Zhang H World J Surg; 2016 Jan; 40(1):100-9. PubMed ID: 26578322 [TBL] [Abstract][Full Text] [Related]
2. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis. Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043 [TBL] [Abstract][Full Text] [Related]
3. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654 [TBL] [Abstract][Full Text] [Related]
4. Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis. Zhao M; Shi X; Zhang J; Deng S; Zhou Y; Wen R; Lu Y; Zhang B Comput Math Methods Med; 2022; 2022():8028846. PubMed ID: 36110571 [TBL] [Abstract][Full Text] [Related]
5. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation. Ahn J; Jeon MJ; Song E; Kim TY; Kim WB; Shong YK; Kim WG Endocrinol Metab (Seoul); 2020 Mar; 35(1):115-121. PubMed ID: 32207271 [TBL] [Abstract][Full Text] [Related]
6. Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis. Zheng W; Li J; Lv P; Chen Z; Fan P Eur J Surg Oncol; 2018 Nov; 44(11):1679-1684. PubMed ID: 30158063 [TBL] [Abstract][Full Text] [Related]
7. Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis. James DL; Ryan ÉJ; Davey MG; Quinn AJ; Heath DP; Garry SJ; Boland MR; Young O; Lowery AJ; Kerin MJ JAMA Otolaryngol Head Neck Surg; 2021 Jun; 147(6):544-552. PubMed ID: 33792650 [TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid microcarcinoma: an over-treated malignancy? Wang TS; Goffredo P; Sosa JA; Roman SA World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670 [TBL] [Abstract][Full Text] [Related]
9. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. Sawka AM; Thephamongkhol K; Brouwers M; Thabane L; Browman G; Gerstein HC J Clin Endocrinol Metab; 2004 Aug; 89(8):3668-76. PubMed ID: 15292285 [TBL] [Abstract][Full Text] [Related]
10. Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients. Xue S; Wang P; Liu J; Chen G World J Surg; 2017 Dec; 41(12):3139-3146. PubMed ID: 28741199 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma]. Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032 [No Abstract] [Full Text] [Related]
12. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting. Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731 [TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid microcarcinomas: big decisions for a small tumor. Haymart MR; Cayo M; Chen H Ann Surg Oncol; 2009 Nov; 16(11):3132-9. PubMed ID: 19653044 [TBL] [Abstract][Full Text] [Related]
14. Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer. Sohn SY; Choi JY; Jang HW; Kim HJ; Jin SM; Kim SW; Suh S; Hur KY; Kim JH; Chung JH; Kim SW Thyroid; 2013 Jun; 23(6):741-7. PubMed ID: 23205883 [TBL] [Abstract][Full Text] [Related]
15. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
16. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis? Han K; Noh HM; Jeong HM; Lim YC Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer. Zhao W; You L; Hou X; Chen S; Ren X; Chen G; Zhao Y Ann Surg Oncol; 2017 Aug; 24(8):2189-2198. PubMed ID: 27913945 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy. Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333 [No Abstract] [Full Text] [Related]
19. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411 [TBL] [Abstract][Full Text] [Related]
20. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center. Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]